BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19590588)

  • 1. Pleiotropic effects of statins in atrial fibrillation patients: the evidence.
    Hadi HA; Mahmeed WA; Suwaidi JA; Ellahham S
    Vasc Health Risk Manag; 2009; 5(3):533-51. PubMed ID: 19590588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy in the prevention and treatment of atrial fibrillation.
    Lee YL; Blaha MJ; Jones SR
    J Clin Lipidol; 2011; 5(1):18-29. PubMed ID: 21262503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation.
    Abuissa H; O'Keefe JH; Bybee KA
    Clin Cardiol; 2009 Oct; 32(10):544-8. PubMed ID: 19911349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of statin use on atrial fibrillation.
    Sánchez-Quiñones J; Marín F; Roldán V; Lip GY
    QJM; 2008 Nov; 101(11):845-61. PubMed ID: 18725372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of Anti-inflammatory Agents in the Prevention of Atrial Fibrillation Recurrences.
    Nomani H; Saei S; Johnston TP; Sahebkar A; Mohammadpour AH
    Curr Med Chem; 2021; 28(1):137-151. PubMed ID: 32116184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis.
    Dentali F; Gianni M; Squizzato A; Ageno W; Castiglioni L; Maroni L; Hylek EM; Grandi AM; Cazzani E; Venco A; Guasti L
    Thromb Haemost; 2011 Aug; 106(2):363-70. PubMed ID: 21614408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.
    Rezaei Y; Gholami-Fesharaki M; Dehghani MR; Arya A; Haghjoo M; Arjmand N
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):167-76. PubMed ID: 26333596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis.
    Bang CN; Greve AM; Abdulla J; Køber L; Gislason GH; Wachtell K
    Int J Cardiol; 2013 Aug; 167(3):624-30. PubMed ID: 22999824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies.
    Liu T; Li L; Korantzopoulos P; Liu E; Li G
    Int J Cardiol; 2008 May; 126(2):160-70. PubMed ID: 18031847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Fang WT; Li HJ; Zhang H; Jiang S
    Br J Clin Pharmacol; 2012 Nov; 74(5):744-56. PubMed ID: 22376147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current role of statin therapy in the treatment of atrial fibrillation.
    Naji F; Sabovic M
    Cardiovasc Hematol Agents Med Chem; 2013 Mar; 11(1):9-13. PubMed ID: 22856623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion.
    Naji F; Suran D; Kanic V; Vokac D; Sabovic M
    Int Heart J; 2009 Mar; 50(2):153-60. PubMed ID: 19367026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
    Naji F; Suran D; Kanic V; Vokac D; Sabovic M
    Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.
    Pinho-Gomes AC; Reilly S; Brandes RP; Casadei B
    Antioxid Redox Signal; 2014 Mar; 20(8):1268-85. PubMed ID: 23924190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.
    Gillis AM; Morck M; Exner DV; Soo A; Rose MS; Sheldon RS; Duff HJ; Kavanagh KM; Mitchell LB; Wyse DG
    Eur Heart J; 2008 Aug; 29(15):1873-80. PubMed ID: 18477727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.